CIVILICA We Respect the Science
(ناشر تخصصی کنفرانسهای کشور / شماره مجوز انتشارات از وزارت فرهنگ و ارشاد اسلامی: ۸۹۷۱)

Survival Rate and Associated Factors of Childhood Leukemia in Iran: A Systematic Review and Meta Analysis

عنوان مقاله: Survival Rate and Associated Factors of Childhood Leukemia in Iran: A Systematic Review and Meta Analysis
شناسه ملی مقاله: JR_JPRE-5-2_002
منتشر شده در در سال 1396
مشخصات نویسندگان مقاله:

Yousef Veisani - Psychosocial Injuries Research Center, Ilam University of Medical Sciences, Ilam, IR Iran
Ali Delpisheh - Department of Clinical Epidemiology, Ilam University of Medical Sciences, Ilam, IR Iran

خلاصه مقاله:
Context: Resent reviews have shown that about ۱۸% of all child cancers are leukemia. Track of the survival rate can help researchers improve quality of life of patients through improving screening or discovery of better treatments. Objectives: This review aimed at estimating the ۵-year survival rates and associated factors of childhood leukemia in Iran. Data Sources: We carried out a systematic review through search of relevant studies published in English (PubMed, Scopus, Google scholar, and ISI) and Persian databases (Magiran, Medlib, SID, and Iran Medex). Study Selection: The study included all epidemiologic studies that estimated survival rate in children with leukemia in Iran during years ۲۰۰۲ to ۲۰۱۵, and a standardized manner was used for extraction of information. Data Extraction: The entire text or summary of all searched articles was extracted and then, related articles were selected, and irrelevant ones were excluded. Fixed and random effects models were calculated by the STATA using standard meta-analysis methods. Heterogeneity was assessed by I² statistics. Results: The overall ۵-year survival rate in patients with childhood leukemia in Iran was ۰.۶۵ (۹۵% CI, ۰.۶۲ to ۰.۶۷, ۱۰ studies), in the acute lymphoblastic leukemia (ALL) subtype was ۷۱.۰% (۹۵% CI: ۶۸.۰ to ۷۴.۰), and in the acute myeloid leukemia (AML) subtype was ۴۶.۰%. Results of the meta analysis showed significant poor survival with relapse (heart rate (HR) ۱.۵۹, ۹۵% confidence interval (CI) ۱.۲۷ to ۱.۹۸) and white blood count (WBC) counts ≥ ۵۰,۰۰۰ (HR ۲.۹۲, ۹۵% CI ۱.۲۳ to ۴.۶۰). Conclusions: The results showed that ۵-year survival rates in patients with AML were lower than patients with ALL. The results of this meta analysis strongly support the need for future research, action, and guidance for clinicians to improve health-related quality of life and outcomes for children with leukemia.

کلمات کلیدی:
Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Survival Rate, Meta-Analysis

صفحه اختصاصی مقاله و دریافت فایل کامل: https://civilica.com/doc/1837577/